EODData

NASDAQ, MRSN: Mersana Therapeutics Inc

07 Nov 25 15:59
LAST:

8.365

CHANGE:
 0.37
OPEN:
8.000
HIGH:
8.430
ASK:
15.630
VOLUME:
21.8K
CHG(%):
4.60
PREV:
8.040
LOW:
7.540
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Nov 258.0008.4307.5408.41034.0K
06 Nov 258.4308.8678.0008.04032.5K
05 Nov 258.2308.6508.1508.46030.6K
04 Nov 259.1509.1508.0008.16062.0K
03 Nov 259.5409.5908.9609.44042.0K
31 Oct 259.3009.8709.2409.58035.0K
30 Oct 259.4909.6109.2409.30026.1K
29 Oct 259.95010.0309.5409.56029.2K
28 Oct 2510.53010.60010.10010.23035.1K
27 Oct 259.90010.6409.87410.59054.5K

COMPANY PROFILE

Name:Mersana Therapeutics Inc
About:Mersana Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops antibody-drug conjugates (ADC) for cancer patients with unmet needs. The company develops Emi-Le (XMT-1660), a B7-H4-targeting Dolasynthen ADC candidate, which is in Phase 1 clinical trial; and XMT-2056, an Immunosynthen ADC targeting a novel human epidermal growth factor receptor 2 that is in Phase 1 clinical trial. Its preclinical products portfolio includes XMT-2068 and XMT-2175. It has strategic research and development collaborations with Janssen Biotech, Inc., Ares Trading S.A., Merck KGaA, and Asana Biosciences, LLC for the development of ADC product candidates. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:840 Memorial Drive, Cambridge, MA, United States, 02139
Website:https://www.mersana.com
CUSIP:59045L106
CIK:0001442836
ISIN:US59045L1061
FIGI:BBG001CPSVF3
LEI:529900VWD5VDZ7PVOS22

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-0.67 
Forward P/E:-13.31 
PEG Ratio:0.00 
Price to Sales:1.34 
Price to Book:-0.89 
Profit Margin:-2.13 
Operating Margin:-6.73 
Return on Assets:-0.34 
Return on Equity:7.28 
EPS Ratio:-14.79 
Revenue:34.77M 
Shares:4.99M 
Market Cap:41.75M 

TECHNICAL INDICATORS

MA5:8.501.6%
MA10:9.189.7%
MA20:9.6114.9%
MA50:8.410.6%
MA100:5.9939.7%
MA200:3.21160.6%
STO9:14.45 
STO14:14.23 
RSI14:35.20 
WPR14:-85.49 
MTM14:-1.64
ROC14:-0.16 
ATR:0.75 
Week High:9.8718.0%
Week Low:7.5410.9%
Month High:11.1533.3%
Month Low:7.54160.6%
Year High:11.1533.3%
Year Low:0.263,131.0%
Volatility:24.33 

RECENT SPLITS

Date Ratio
28 Jul 20251-25